A study of more than 5,000 breast cancer patients found that multi-gene sequencing has rapidly replaced BRCA1/2-only tests, resulting in better pathogenic variant detection but also higher VUS rates.
A Color Genomics collaborator reported that nearly half of first-degree relatives who were invited for reduced-cost testing in cancer-related genes opted to participate.
The researchers said that their reagent, which makes TB cells emit light, could be integrated into slide-and-microscope testing platforms.
As a clinical study seeks to decide whether low levels of PCT can guide antibiotic therapy, researchers are exploring alternate, gene expression biomarkers.
A test being developed by researchers at Stanford University and Enable Biosciences could be used for HIV screening sooner than traditional immunoassays.
Its CEO said that although a hospital screening test for sepsis is a focus, a fever test that informs about antibiotic use could be available sooner.
The funding will support further development of an existing serum-based assay and expansion of the test to use saliva samples.
The funding will be used to support the the newly established ME/CFS Collaborative Research Center at Stanford University.
The team has developed a method to test for inherited disorders prenatally and plan to conduct a larger trial and eventually offer it as a clinical test.
The initiative's four research projects will use use genetic and other technologies to detect and treat cancer at its earliest stages.